Literature DB >> 1965104

Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans.

G St-Germain1.   

Abstract

The in vitro interaction of pentamidine with ketoconazole and with itraconazole was studied with 10 strains of Candida albicans isolated from acquired immunodeficiency syndrome patients and one azole-resistant strain. Although growth curves indicated that concentrations of 1 microgram or more of pentamidine per ml significantly inhibited the growth of C. albicans, MICs and minimum fungicidal concentrations (MFCs) were greater than or equal to 10 micrograms/ml. Combinations of ketoconazole and pentamidine did not appear to have any significant effect on MICs or MFCs with most strains. However, the azole-resistant strain exhibited a 2-log decrease in MIC when exposed to ketoconazole combined with 1.0 microgram or more of pentamidine per ml. Similar results were obtained with itraconazole. An Eagle, or paradoxical, effect was observed with four strains exposed to itraconazole alone and in combination with 0.01 and 0.1 microgram of pentamidine per ml. This effect was not seen when concentrations of pentamidine reached 1.0 microgram/ml. Although no fungicidal effect was observed with any of these drugs alone, itraconazole combined with 10 micrograms of pentamidine per ml was fungicidal for eight strains. No signs of antagonism between pentamidine and these two antifungal agents were observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965104      PMCID: PMC172051          DOI: 10.1128/AAC.34.12.2304

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Effect of diamidines on Candida albicans in vitro.

Authors:  A STENDERUP
Journal:  Acta Pathol Microbiol Scand       Date:  1955

2.  Moniliasis treated with pentamidine.

Authors:  A STENDERUP; J BICHEL; F KISSMEYER-NIELSEN
Journal:  Lancet       Date:  1956-01-07       Impact factor: 79.321

3.  Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions.

Authors:  F C Odds; A B Abbott; G Pye; P F Troke
Journal:  J Med Vet Mycol       Date:  1986-08

4.  Ketoconazole and the liver.

Authors:  C R Horseburgh; C H Kirkpatrick; C B Teutsch
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

5.  Azole resistance in Candida albicans.

Authors:  J F Ryley; R G Wilson; K J Barrett-Bee
Journal:  Sabouraudia       Date:  1984

6.  Paradoxical effect of antibiotics. I. The 'Eagle effect'.

Authors:  P M Shah
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

7.  Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.

Authors:  G S Hall; C Myles; K J Pratt; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 8.  Pentamidine: a review.

Authors:  M Sands; M A Kron; R B Brown
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

9.  Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

Authors:  M Radetsky; R C Wheeler; M H Roe; J K Todd
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

10.  Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends.

Authors:  R M Selik; E T Starcher; J W Curran
Journal:  AIDS       Date:  1987-09       Impact factor: 4.177

View more
  6 in total

Review 1.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

Review 2.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibition.

Authors:  K E Miletti; M J Leibowitz
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

4.  Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Authors:  Luis Ostrosky-Zeichner; John H Rex; Peter G Pappas; Richard J Hamill; Robert A Larsen; Harold W Horowitz; William G Powderly; Newton Hyslop; Carol A Kauffman; John Cleary; Julie E Mangino; Jeannette Lee
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents.

Authors:  M Del Poeta; W A Schell; C C Dykstra; S Jones; R R Tidwell; A Czarny; M Bajic; A Kumar; D Boykin; J R Perfect
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

6.  Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.

Authors:  M Fleischhacker; C Radecke; B Schulz; M Ruhnke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-04       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.